Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Revenue (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Revenue for 16 consecutive years, with $64.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 15.68% to $64.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $249.6 million, a 13.53% increase, with the full-year FY2025 number at $249.6 million, up 13.53% from a year prior.
  • Revenue was $64.5 million for Q4 2025 at Lemaitre Vascular, up from $61.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $64.5 million in Q4 2025 to a low of $35.9 million in Q1 2021.
  • A 5-year average of $49.0 million and a median of $48.1 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 63.66% in 2021, then grew 1.72% in 2022.
  • Lemaitre Vascular's Revenue stood at $39.5 million in 2021, then grew by 3.67% to $41.0 million in 2022, then grew by 19.36% to $48.9 million in 2023, then rose by 13.98% to $55.7 million in 2024, then grew by 15.68% to $64.5 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Revenue are $64.5 million (Q4 2025), $61.0 million (Q3 2025), and $64.2 million (Q2 2025).